文献速递肺外科

度伐利尤单抗联合放化疗所致支气管胸膜瘘的挽救性手术

Salvage Surgery for Bronchopleural Fistula Due to Durvalumab and Chemoradiation.
PubMed 文献 · Ann Thorac Surg · 2021-12-30

本文报道一例初始不可切除非小细胞肺癌患者,接受放化疗后度伐利尤单抗治疗,停药14个月后发生肺炎继发周围型支气管胸膜瘘,行挽救性右上肺叶切除术,术后经过平稳,漏气停止。

要点

  • 放化疗后度伐利尤单抗治疗可能发生肺炎并继发支气管胸膜瘘。
  • 顽固性漏气可能需要挽救性手术干预。
  • 本例挽救性右上肺叶切除术后经过平稳,漏气停止。

核心结论

  • 放化疗和度伐利尤单抗治疗后可能发生顽固性漏气,可能需要挽救性手术。

研究设计与样本

  • 病例报告:75岁男性,右肺上叶腺癌,c-stage IIIB(T4N2M0),初始不可切除,接受放化疗后度伐利尤单抗治疗。

主要发现

  • 度伐利尤单抗停药14个月后发生肺炎,随后出现周围型支气管胸膜瘘,不得已行挽救性右上肺叶切除术。
  • 术后经过平稳,漏气停止。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Herein we describe a case of salvage lobectomy for a bronchopleural fistula secondary to durvalumab after chemoradiotherapy in initially unresectable non-small cell lung cancer. A 75-year-old man with adenocarcinoma, c-stage IIIB (T4N2M0) in the upper lobe of the right lung, received durvalumab after chemoradiotherapy. Fourteen months after durvalumab was discontinued, pneumonitis developed followed by peripheral bronchopleural fistula, and he unavoidably underwent salvage right upper lobectomy. The postoperative course was uneventful, and air leakage ceased. After chemoradiotherapy and durvalumab, refractory air leakage may develop that may require salvage surgery.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Tada M, Uehara H, Ohyu T, et al. Salvage Surgery for Bronchopleural Fistula Due to Durvalumab and Chemoradiation. Ann Thorac Surg. 2021. PMID: 34973185. doi:10.1016/j.athoracsur.2021.11.063

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。